Article | July 15, 2024

Taking A Proactive, Preventive Approach To Data Privacy In Clinical Documentation

Source: Parexel International

By Simin Takidar, Senior Principal Medical Writer; and Bipasha Das, Head of the Parexel Clinical Trial Disclosure Group

Personal data security-GettyImages-1172943967

Data privacy has become critical as citizens demand control over their data, supported by global regulations. The EU Clinical Trials Regulation (EU-CTR 536/2014) and GDPR mandate transparency and patient privacy in clinical trials, posing challenges for documentation, especially in rare diseases. Compliance requires understanding the role of data controllers, robust redaction, and anonymization processes.

Common pitfalls include inadequate technical measures, insufficient insight, and over-reliance on manual or automated redaction methods. Parexel Regulatory Consulting Services offers an end-to-end solution with AI-driven tools for identifying sensitive data, combined with regulatory expertise to ensure compliance and efficiency. Their approach includes proactive privacy measures and detailed regulatory guidance to support smooth and timely submissions.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader